Centene Corporation Announces Chief Information Officer Changes, Effective August 31, 2026

Centene Corporation (CNC) reaffirmed its 2026 adjusted diluted EPS forecast, expecting it to exceed $4.80, slightly below analyst consensus. The company's P/S ratio is 0.16, below its historical median and industry average, reflecting market skepticism. Its GF Score™ is 72/100, indicating moderate financial health. Insider activity shows no buying and $14.6 million in selling, while institutional sentiment is mixed.

Centene Corp. (CNC) and Archer-Daniels-Midland Co. (ADM) are highlighted for strong performance and attractive valuations. CNC expects 2026 revenues of $173-$177B and adjusted EPS over $4.80, with a forward P/E of 13.58X. ADM raised 2026 adjusted earnings guidance to $5.15-$5.60 per share, with a forward P/E of 16.60X.

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.

Centene Corporation (CNC) appointed Bradley Bolivar as its new Chief Information Officer, replacing Brian LeClaire. Bolivar brings extensive tech leadership experience, including roles at Fannie Mae and Warner Bros. Centene reported Q2 earnings of $2.19 GAAP EPS and $2.51 adjusted EPS, raising its full-year adjusted EPS guidance above $4.80. The company's health benefits ratio improved, but total at-risk membership declined. Centene trades at a forward P/E ratio of 13.12 as of September 1.

Centene Corporation (CNC) reported improved profitability in its Marketplace business, with a health benefits ratio of 79.2% in Q2 2026, down from 90.6% a year ago. The company expects a 4.5%-5% pretax margin for 2026, up from a previous 3% outlook. Competitors UnitedHealth (UNH) and Elevance Health (ELV) are also focusing on profitability. CNC shares have surged 56.4% YTD, with a forward P/E of 12.39. Analysts estimate $4.89 EPS for 2026, a 135.1% increase.

UnitedHealth Group reported $5B in Q2 net income, with a declining medical care ratio. Shares of UnitedHealth, CVS Health, Centene, and Humana have risen significantly. Centene and Humana reported strong earnings, while Humana plans to exit some markets in 2027. Oscar Health entered new markets and saw its stock triple in six months.